1. Liu, Tao, Xiang, Wan, Chen, Zhizhuang, Luo, Yongwen, Chen, Liang. 2023. Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation. In Cell death & disease, 14, 774. doi:10.1038/s41419-023-06298-7. https://pubmed.ncbi.nlm.nih.gov/38008826/
2. Van den Langenbergh, J, Bastiaansen-Jenniskens, Y M, van Osch, G J V M, Mechlenburg, I, Clockaerts, S. 2024. PLOD2 gene expression in infrapatellar fat pad is correlated with fat mass in obese patients with end-stage knee osteoarthritis. In Osteoarthritis and cartilage open, 6, 100469. doi:10.1016/j.ocarto.2024.100469. https://pubmed.ncbi.nlm.nih.gov/38694906/
3. Wang, Zhen, Fan, Gentao, Zhu, Hao, Zhao, Jianning, Zhou, Guangxin. 2022. PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma. In Frontiers in oncology, 12, 980390. doi:10.3389/fonc.2022.980390. https://pubmed.ncbi.nlm.nih.gov/36276118/
4. Megarbane, Andre, Bizzari, Sami, Deepthi, Asha, Delague, Valérie, Urtizberea, J Andoni. . A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort. In Journal of neuromuscular diseases, 9, 193-210. doi:10.3233/JND-210652. https://pubmed.ncbi.nlm.nih.gov/34602496/
5. Li, Keren, Niu, Yi, Li, Kai, Yuan, Yunfei, Li, Binkui. 2023. Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma. In Journal of clinical and translational hepatology, 11, 1094-1105. doi:10.14218/JCTH.2022.00401. https://pubmed.ncbi.nlm.nih.gov/37577214/
智鼠故事 
